- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03776396
Perioperative Goal Directed Therapy in Kidney Transplantation
December 11, 2018 updated by: Marinella Astuto, University of Catania
Perioperative Protocol Goal Directed Therapy in Kidney Transplantation: Fluid Therapy Optimization and Impact on Postoperative Complications.
In literature there is a huge amount of works demonstrating the direct correlation between volemic overload or fluid deficit and hypoperfusion and the increase in the rate of major postoperative complications in patients with high cardiovascular risk and chronic renal failure candidate to kidney transplantation from cadaver.
It is also widely demonstrated that in certain populations with high surgical and post-operative complications risk, the adoption of targeted haemodynamic and clinical-therapeutic management protocols is indicated.
The current trend is therefore to guarantee greater precision in the intraoperative management of patients undergoing kidney transplantation from cadaver by using a specific protocol that can be framed in the recent and innovative concept of Perioperative Gold Directed Therapy (PGDT), resulting from the adoption of an advanced minimally invasive hemodynamic monitoring technology with a special sensor called FloTrac (Edwards Lifesciences), already extensively tested in an extensive case series of high perioperative risk patients underwent to major abdominal surgery, major vascular surgery, major orthopedic surgery and cardio-thoracic surgery.
In the present study there will be enrolled all patients who are candidates for kidney transplant from cadaver at the University Hospital "G.
Rodolico" of Catania that meet the inclusion criteria of the study and will give their informed consent to participation.
The enrolled patients will be monitored for a maximum period of 7 days from transplantation.
As control group there will be considered an historical cohort of patients who underwent kidney transplantation from cadaver in 2015, in which a PGDT protocol was not used, but a common hemodynamic monitoring, based on parameters such as central venous pressure and / or invasive arterial pressure, was performed according to the international guidelines.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
66
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Catania, Italy, 95123
- "G. Rodolico" Presidium of the Azienda Ospedaliero Universitaria "Policlinico-Vittorio Emanuele"
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
33 consecutive patients candidates for kidney transplantation from cadaver that meet the eligibility criteria of the study and 33 patients who underwent kidney transplantation in 2015
Description
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) Classification III-IV;
- Age between 18 and 65 years;
- First kidney transplantation from cadaver;
- Absence of atrial fibrillation or severe arrhythmia;
- Informed consent.
Exclusion Criteria:
- Lack of informed consent;
- Age less that 18 or greater than 65 years;
- Atrial fibrillation and high frequency tachyarrhythmias;
- Previous transplantation from cadaver.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Experimental cohort
33 patient undergoing to kidney transplantation from cadaver at University Hospital "G.
Rodolico" of Catania, in which an innovative Perioperative Goal Directed Therapy (PGDT) protocol will be used.
|
Historical control group
33 patients underwent to kidney transplantation from cadaver at University Hospital "G.
Rodolico" of Catania in 2015, in which a PGDT protocol was not used, but a common hemodynamic monitoring, based on parameters such as central venous pressure and / or invasive arterial pressure, was performed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency rate of postoperative complications
Time Frame: 7 days after transplantation
|
The frequency rate of the subsequent postoperative complications in the two study cohort will be determined: early postoperative pulmonary complications (prolonged mechanical ventilation, failure acute respiratory disease, acute pulmonary edema, pulmonary infections); major cardiovascular complications (ischemic cardiac events and heart failure congestive); major surgical complications (anastomosis, delayed postoperative ileum, nausea and postoperative vomiting).
|
7 days after transplantation
|
Duration of hospitalization in a semi-intensive and intensive hospital ward.
Time Frame: 7 days after transplantation
|
7 days after transplantation
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of patients with delayed graft failure in the two study cohorts
Time Frame: 7 days after transplantation
|
7 days after transplantation
|
Number of patients requiring hemodialysis in the two study cohorts
Time Frame: 7 days after transplantation
|
7 days after transplantation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 5, 2016
Primary Completion (Actual)
January 19, 2018
Study Completion (Actual)
January 30, 2018
Study Registration Dates
First Submitted
December 6, 2018
First Submitted That Met QC Criteria
December 11, 2018
First Posted (Actual)
December 14, 2018
Study Record Updates
Last Update Posted (Actual)
December 14, 2018
Last Update Submitted That Met QC Criteria
December 11, 2018
Last Verified
December 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 31/2016/PO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Transplant; Complications
-
University of MinnesotaWithdrawnKidney Transplant Rejection | Kidney Transplant; Complications | Kidney Transplant FailureUnited States
-
Ohio State UniversityActive, not recruitingKidney Transplant; Complications | Kidney TransplantUnited States
-
University of LiegeRecruitingKidney Transplant Rejection | Kidney Transplant; ComplicationsBelgium
-
PilloxaTerminatedLiver Transplant; Complications | Kidney Transplant; ComplicationsSweden
-
Seoul National University HospitalSamsung Medical Center; Asan Medical Center; Korea University; Yonsei University; Gachon University Gil Medical Center and other collaboratorsUnknownKidney Transplant Recipients | Complications After Kidney TransplantKorea, Republic of
-
Natera, Inc.RecruitingKidney Transplant Rejection | Kidney Transplant; Complications | Allograft RejectionUnited States
-
California Institute of Renal ResearchUniversity of California, San Diego; Balboa Institute of TransplantationRecruitingKidney Transplant; Complications | Kidney Transplant Failure and RejectionUnited States
-
University of MinnesotaCompletedKidney Transplant Rejection | Kidney Transplant; Complications | Transplant; Complication, Rejection | Kidney Transplant Failure and Rejection | Transplant DysfunctionUnited States
-
Singapore General HospitalRecruitingKidney Transplant Infection | Kidney Transplant Rejection | Kidney Transplant; ComplicationsSingapore
-
Western Sydney Local Health DistrictRecruitingKidney Transplant Rejection | Kidney Transplant; ComplicationsAustralia